We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Interaction of Gut Cells with Bacterial Outer Membrane Vesicles Triggers Inflammatory Bowel Disease in Mouse Model

By LabMedica International staff writers
Posted on 26 May 2015
Interaction of bacterial outer membrane vesicles (OMVs) harboring sulfatase activity with the cells lining the gut has been implicated as a key step in the development of inflammatory bowel diseases (IBDs) such as Crohn's disease and ulcerative colitis.

Sulfatases are enzymes of the esterase class that catalyze the hydrolysis of sulfate esters. More...
These moieties may be found on a range of substrates, including steroids, carbohydrates and proteins. Sulfatases play important roles in the cycling of sulfur in the environment, in the degradation of sulfated glycosaminoglycans and glycolipids in the lysosome, and in remodeling sulfated glycosaminoglycans in the extracellular space.

Investigators at the Washington University School of Medicine (St. Louis, MO, USA) worked with a genetically engineered mouse model (dnKO) that developed spontaneous, fulminant colitis when triggered by the Gram-negative, obligatory anaerobic bacterium Bacteroides thetaiotaomicron.

Results published in the May 13, 2015, issue of the journal Cell Host & Microbe revealed that B. thetaiotaomicron antigens localized to host immune cells through outer membrane vesicles (OMVs) that harbored bacterial sulfatase activity. Access of B. thetaiotaomicron OMVs to host immune cells was sulfatase dependent.

OMVs are a means for bacteria to communicate among themselves and with other living forms in their environment via nanoscale membrane vesicles in their outer membranes. These vesicles are involved in trafficking bacterial cell signaling biochemicals, which may include DNA, RNA, proteins, endotoxins, and allied virulence molecules.

The investigators deleted the anaerobic sulfatase maturating enzyme (anSME), which is required for post-translational activation of all sulfatase enzymes, from B. thetaiotaomicron. This bacterial mutant strain did not stimulate colitis in dnKO mice.

"The immune cells do not need to encounter the bacteria to cause inflammation—all they need to do is encounter the vesicles," said senior author Dr. Thad Stappenbeck, professor of pathology and immunology at the Washington University School of Medicine. "We did not realize that was possible, and we think this discovery could change our thinking about not just IBD but other autoimmune disorders and infectious diseases."

Related Links:

Washington University School of Medicine


New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.